CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Challenges, Methods, And Solutions For Obtaining Optimal Starting Material

  For innovative treatments like CAR-T and stem cell transplants, optimal starting material is key. Understanding collection challenges and new solutions helps ensure the best foundation for these therapies.

• Biopharma Production And Quality Control With Electrophoresis

  Discover how Kaneka Eurogentec, a leading provider of custom DNA synthesis and molecular biology services, enhanced their fragment analysis to achieve higher efficiency and accuracy in their workflows.

• Enhance Access And Improve Retention In Rare Disease Trials With HTS

  Home Trial Support (HTS) provides a solution to improving participant recruitment and retention during musculoskeletal studies.

• How Can You Avoid Bioprocessing Risks When Using Cable Ties?

  Cable ties in bioprocessing can cause leaks, damage, and delays. See how switching to a uniform-sealing connector can significantly improve efficiency, reduce prep time, and minimize contamination risks.

• A Paradigm Shift From Glass Benchtop Bioreactors

  Learn how a bench-scale single-use bioreactor offers process development advantages over traditional glass systems, including higher efficiency, increased productivity, and enhanced sustainability.

• Co-Precipitation Of Metal Carbonate Templated Protein Microparticles

  Explore the automated production of protein microparticles using an innovative method that offers a standardized and scalable solution for co-precipitation in biopolymer particle fabrication.

• Navigating The CGT Supply Chain: Key Logistical Challenges And Solutions

  Commercializing cell and gene therapies requires overcoming complex logistical hurdles. Customized strategies for temperature control, compliance, and end-to-end delivery are crucial to prevent supply chain issues.

• A Scalable Manufacturing Platform For The Purification Of Stem Cell Derived Exosomes

  EV production scale increases require paired robust, scalable, and cost-effective downstream processes. Process parameters can be tailored for therapeutic exosome programs and allow for maximum exosome recovery.

• Pave The Way To High Productivity With Continuous Manufacturing For Pharma

  Continuous manufacturing delivers agility and precision for pharma, combining automation, reduced manual steps, and quality control to meet regulatory and cost pressures while accelerating development.

• A Shift Towards Biofluorescent Particle Counters In Manufacturing

  Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.